Kathy Hopinkah Hannan - Aug 2, 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role: Director
Signature: /s/ Karen Tepichin, Attorney-in-Fact
Stock symbol: DNA
Transactions as of: Aug 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/4/2022, 09:09 PM
Previous filing: May 23, 2022
Next filing: Oct 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNA	Class A Common Stock	Award	$0	+57K	+1139.72%	$0.00	62K	Aug 2, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNA	Stock Option	Award	$0	+84.2K		$0.00	84.2K	Aug 2, 2022	Class A Common Stock	84.2K	$2.03	Direct	F1, F2
transaction	DNA	Stock Option	Award	$0	+187K		$0.00	187K	Aug 2, 2022	Class A Common Stock	187K	$2.14	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The vesting date of the RSUs and additional stock options, and in the case of the additional stock options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
F2	In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is a prorated amount based on $200,000.
F3	The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
F4	In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is $400,000.